Skip to main content.

Pooja Bhadbhade, DO

Pooja Bhadbhade portrait

Professional Background

I graduated medical school from Kansas City University of Medicine and Biosciences Osteopathic medical school. I then completed my internal medicine residency at the University of Kansas Medical Center, followed by my fellowship in Rheumatology at the University of Kansas Medical Center. I currently practice at the University of Kansas Medical Center as an Adult Rheumatologist and help train the rheumatology fellows. I also work with first and second year medical students once a week. I have particular interest in inflammatory arthritis, musculoskeletal ultrasound and procedures.

Education and Training
  • DO, Doctor of Osteopathic Medicine , Kansas City Univ of Med&BioSci, KANSAS CITY, Missouri
  • Clinical Fellowship, Rheumatology , University of Kansas Medical Center , Kansas City, KS
  • Internship, Internal Medicine , University of Kansas Medical Center , Kansas City, KS
  • Residency, Internal Medicine , University of Kansas Medical Center , Kansas City, KS
Licensure, Accreditations & Certifications
  • Musculoskeletal Ultrasound Certification in Rheumatology - RhMSUS, University of Kansas Medical Center
  • Rheumatology Certification Exam, American Board of Internal Medicine
  • USSONAR, The Ultrasound School of North American Rheumatologists
Professional Affiliations
  • American College of Rheumatology Member, American College of Rheumatology (ACR), Member, 2015 - Present

Publications
  • Bhadbhade, Pooja, Noaiseh, Ghaith. 2020. Crystal Arthropathies. Cecil Essentials of Medicine 10e
  • O'Connor, Patrick , Bhadbhade, Pooja, Pritchett, Michael, Laury, Raquele, Sami, Farhad , Amos, Jonathon, Sharma, Priyanka , Williamson, Stephen. 2020. Acral vascular syndrome during an immune checkpoint inhibitor. BMJ Case Reports, 13 (5)
  • Medcalf, Matthew, Bhadbhade, Pooja, Mikuls, Ted., R, O'Dell, James., R, Gundry, Rebekah., L, Funk, Ryan., S. 2021. Plasma Metabolome Normalization in Rheumatoid Arthritis Following Initiation of Methotrexate and the Identification of Metabolic Biomarkers of Efficacy. Metabolites, 11 (12)
  • Medcalf, Matthew, Bantis, Leonidas, Shi, Peng, Bhadbhade, Pooja, Gundry, Rebekah, Mikuls, Ted, England, Bryant, O'Dell, James., R, Funk, Ryan. 2022. Plasma metabolomic profiling as a tool to identify predictive biomarkers of methotrexate efficacy in rheumatoid arthritis. Seminars in Arthritis and Rheumatism, 56
  • Smolen, Josef, Feist, Eugen, Fatenejad, Saeed, Grishin, Sergey, Korneva, Elena, Nasonov, Evgeniy, Samsonov, Mikhail, Fleischmann, Roy, CREDO Group. 2022. Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis . The New England Journal of Medicine, 715-726. https://www-nejm-org.kumc.idm.oclc.org/doi/pdf/10.1056/NEJMoa2201302
  • Kumar, Amar, Arain, Mudassar., Iqbal, Bhadbhade, Pooja , Funk, Ryan. 2023. Erythrocyte Folyl Polyglutamate Synthetase Activity Profiling as a Potential Tool for the Prediction of Methotrexate Efficacy and Toxicity in Rheumatoid Arthritis. Future Pharmacology, 3 (4), 819-833